dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Recrudescence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, RA; Clements, JA; Heilbron, DC; Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, SH; Tooley, WH; Wakeley, A | 1 |
1 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Recrudescence
Article | Year |
---|---|
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membrane Disease; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Recurrence; Regression Analysis; Respiration, Artificial; Time Factors | 1991 |